Skip to Main Content

Paper Details

Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer.
Cell
161
2017
-mutant NSCLC cells, Genetically, KEAP1, KEAP1-mutant NSCLC, KEAP1-mutant NSCLC cells, KEAP1-mutant cancer cells, NR0B1, NR0B1 complexes, NR0B1 protein interaction domain, NRF2, NRF2-dependent lung cancers, NSCLC, NSCLCs, cancer, cancer cells, cysteine, non-small-cell lung cancers
Author NameAffiliation
Max W ChangUniversity of California
Zhou ZhuOncology Research Unit
Benjamin F CravattThe Skaggs Institute for Chemical Biology and Department of Molecular Medicine, The Scripps Research Institute
  • 1 - 3

Datasets

Release 1.2